This Amendment No. 37 (Amendment No. 37) amends the statement on Schedule 13D filed
with the Securities and Exchange Commission (the SEC) on January 31, 2022, as amended prior to the date of this Amendment No. 37 (the Original Schedule 13D) as specifically set forth herein (as so amended, the
Schedule 13D). Except as provided herein, each Item of the Original Schedule 13D remains unchanged.
Item 3. |
Source and Amount of Funds or Other Consideration. |
Item 3 of the Original Schedule 13D is hereby amended to add the following:
On August 7 and August 8, as set forth in Schedule A, Philip A. Norcross, acting through an individual retirement account for his
benefit, acquired 47,000 shares of Common Stock through a broker on the open market for a total of approximately $44,494.90. The source of funds for such purchases was funds held in such account.
On August 7 and August 8, as set forth in Schedule A, Gregory B. Braca acquired 49,275 shares of Common Stock through a broker on
the open market for a total of approximately $48,620.49. The source of funds for such purchases was personal funds.
On August 7 and
August 8, as set forth in Schedule A, Alessandra T. Norcross acquired 252,450 shares of Common Stock through a broker on the open market for a total of approximately $249,106.57. The source of funds for such purchases was personal funds.
On August 7 and August 8, as set forth in Schedule A, Alexander S. Norcross acquired 324,000 shares of Common Stock through a broker
on the open market for a total of approximately $320,061.93. The source of funds for such purchases was personal funds.
Item 4. |
Purpose of the Transaction. |
Item 4 of the Original Schedule 13D is hereby amended to add the following immediately prior to the last paragraph of this item:
On August 8, 2023, the Group filed a preliminary proxy statement on Schedule 14A with the SEC in connection with the Groups
nomination of the Nominees for election to the Board of the Issuer at the Issuers 2022 annual meeting of shareholders.
Item 5. |
Interest in Securities of the Issuer. |
Items 5(a) and 5(c) of the Original Schedule 13D are hereby amended and restated as follows:
(a) The Reporting Persons may be deemed to beneficially own 6,984,343 shares of Common Stock or approximately 9.95% of the outstanding shares
of Common Stock, which percentage was calculated based upon 70,183,407 shares of Common Stock outstanding as of August 3, 2023 as reported by the Issuer in its Current Report on Form 8-K, filed with the
SEC on August 7, 2023. Specifically, each Reporting Person beneficially owns such number of shares of Common Stock and such percentage of the outstanding Common Stock as reflected on Items 11 and 13 of the applicable cover page to this
Statement.
(c) Except as set forth on Schedule A attached hereto, none of the Reporting Persons has engaged in transactions in shares of
Common Stock (or securities convertible into, exercisable for or exchangeable for Common Stock) since the filing of the Original Schedule 13D.